MON up +0.63% percent right now. $MON High is at 115.48 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
MON up +0.63% percent right now. $MON High is at 115.48 and the Low 114.50 with current volume of 1,094,134.

Recent News posted below.

MON Monsanto Company Recent Headline News

Will Evogene (EVGN) Report Wider-than-Expected Q3 Loss? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 4:10PM CST
Evogene (EVGN) is scheduled to report third-quarter 2014 results before the opening bell on Nov 10.
MNK: 92.87 (+1.81), EVGN: 10.37 (-0.13), MON: 116.70 (+2.26), DNDN: 0.22 (-0.72)

Investments, Quarterly Results, and Upcoming Conferences - Research Reports on ExxonMobil, Chevron, Halliburton, Schlumberger and Monsanto
PR Newswire - Fri Nov 07, 8:30AM CST
Today, Analysts Review released its research reports regarding Exxon Mobil Corporation (NYSE: XOM), Chevron Corporation (NYSE: CVX), Halliburton Company (NYSE: HAL), Schlumberger Limited (NYSE: SLB) and Monsanto Company (NYSE: MON). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7794-100free.
MON: 116.70 (+2.26), HAL: 53.50 (-0.36), XOM: 96.32 (-0.27), CVX: 117.71 (-1.09), SLB: 98.33 (-0.40)

What A Strong U.S. Dollar Means For Investors, Consumers, Companies, And The Economy
Michael Maggi, CFA - at Seeking Alpha - Fri Nov 07, 7:18AM CST

KO: 42.33 (+0.01), MON: 116.70 (+2.26), IBM: 163.80 (+1.73), MCD: 95.21 (+0.11), XOM: 96.32 (-0.27), INTC: 33.23 (-0.35), CVX: 117.71 (-1.09), DOW: 49.50 (unch), SLB: 98.33 (-0.40)

Business Highlights
By The Associated Press - AP - Thu Nov 06, 4:56PM CST
___
MON: 116.70 (+2.26), LNKD: 229.49 (+6.45)


Despite losses, GMO label backers aren't quitting
By GOSIA WOZNIACKA - AP - Thu Nov 06, 11:04AM CST
PORTLAND, Ore. (AP) — In the end, not even Oregon's backyard chicken owners and vegan foodies had enough money and clout to persuade voters to pass a ballot measure that would have required labeling of genetically modified foods.
MON: 116.70 (+2.26)

Monsanto - Desirable Dividend Fundamentals, But Pricey
Dividends4Life - Seeking Alpha - Thu Nov 06, 1:13AM CST
Linked here is a detailed quantitative analysis of Monsanto Co. (NYSE: MON ). Below are some highlights from the above linked analysis: Company Description: Monsanto Co. is a global provider of agricultural products and integrated solutions for...
MON: 116.69 (+2.25)

5 Things to Know About Massachusetts Casinos
By PHILIP MARCELO - AP - Wed Nov 05, 11:10AM CST
BOSTON (AP) — The march toward Las Vegas-style gambling in the Bay State begins in earnest now that voters have resoundingly defeated a ballot question to repeal the state's 2011 casino law. Anti-casino advocates have left the door open for another repeal effort someday, but the following is a closer look at what's on the horizon for Massachusetts' nascent casino industry:
MON: 116.69 (+2.25)

20 Stocks That Could Beat the Market in November: Priceline, U.S. Steel Lead Way
at The Street - Wed Nov 05, 10:24AM CST
Which stocks have historically done the best in November, typically one of the best months to invest?
BIIB: 327.09 (+6.34), MNST: 107.34 (-1.05), ATI: 31.82 (-0.86), MON: 116.69 (+2.25), GMCR: 155.05 (+2.15), VMC: 65.42 (+0.31), EMR: 65.00 (+0.14), WDC: 97.61 (-0.09), VRSN: 60.40 (+0.60), URBN: 30.54 (-0.64), FSLR: 51.87 (+1.58), DE: 88.38 (-0.28), EXPE: 85.91 (+0.80), FLR: 65.90 (-0.39), FLS: 67.74 (-0.16), X: 36.68 (-0.89), ROK: 112.61 (+0.32), REGN: 386.00 (+8.16), MA: 84.90 (+0.10)

Maui votes to ban genetically modified organisms
By AUDREY McAVOY - AP - Wed Nov 05, 5:01AM CST
HONOLULU (AP) — Maui County voters opted Tuesday to temporarily ban the cultivation of genetically engineered crops after a hard-fought campaign featuring $8 million in advertising from some of the world's largest corn-seed producers.
MON: 116.69 (+2.25), DOW: 49.50 (unch)

Mosanto's Solid Fundamentals And High Growth Should Entice Investors
Vuru - Seeking Alpha - Fri Oct 31, 5:51AM CDT
Monsanto Company (NYSE: MON ) , together with its subsidiaries, provides agricultural products for farmers in the US and internationally. The company operates in two segments, seeds and genomics, and agricultural productivity. The seeds and genomics...
MON: 116.69 (+2.25)

Are XLB And Materials Overpriced?
Fred Piard - at Seeking Alpha - Thu Oct 30, 1:46PM CDT

XLB: 48.75 (+0.11), LYB: 87.94 (+0.48), MON: 116.71 (+2.27), DD: 70.71 (+0.30), PX: 126.28 (-0.39), PPG: 205.87 (-1.03), DOW: 49.50 (unch), APD: 134.89 (-0.05), ECL: 112.61 (+0.13)

Herbicides Market by Type (Glyphosate, Atrazine, Acetochlor, 2,4-D), by Crop Type (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables), by Mode of Action (Selective & Non-Selective) & Geography - Trends and Forecasts to 2019
PR Newswire - Thu Oct 30, 1:10PM CDT
Herbicides are used to kill undesirable plants and weeds. They are a very essential part of modern agricultural practices. The herbicides market is dominated by players such as Syngenta (Switzerland), BASF (Germany), Dow AgroSciences (U.S.), Monsanto Company (U.S.), and DuPont (U.S.). Being a highly regulated market, government intervention in the supply and demand of herbicides increases competition among manufacturers.
MON: 116.71 (+2.27)

Stock Market News for October 30, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 9:10AM CDT
Benchmarks slipped into the red zone on Wednesday after the Federal Reserve ended its quantitative easing program
DHI: 23.41 (+0.28), MON: 116.71 (+2.27), FB: 74.95 (-0.65), BZH: 19.20 (+0.64), LEN: 45.30 (+0.76), LNKD: 229.49 (+6.45), PHM: 20.28 (+0.32), DD: 70.71 (+0.30), TWTR: 39.63 (-0.68), YELP: 59.13 (+0.72), PX: 126.28 (-0.39), TOL: 33.06 (+0.84), DOW: 49.50 (unch), ECL: 112.61 (+0.13)

New Services, Upcoming Earnings Releases, Quarterly Results, Oil Discovery, and Recognitions - Research Reports on Schlumberger, ExxonMobil, Halliburton, Chevron and Monsanto
PR Newswire - Thu Oct 30, 7:55AM CDT
Today, Analysts Review released its research reports regarding Schlumberger Limited (NYSE: SLB), Exxon Mobil Corporation (NYSE: XOM), Halliburton Company (NYSE: HAL), Chevron Corporation (NYSE: CVX) and Monsanto Company (NYSE: MON). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7565-100free.
MON: 116.71 (+2.27), HAL: 53.52 (-0.34), XOM: 96.32 (-0.27), CVX: 117.71 (-1.09), SLB: 98.34 (-0.39)

SmarTrend Watching for Potential Rebound in Shares of Monsanto After 1.15% Loss
Comtex SmarTrend(R) - Wed Oct 29, 3:40PM CDT
Monsanto (NYSE:MON) traded in a range yesterday that spanned from a low of $111.68 to a high of $114.20. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $112.13 on volume of 5.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MON: 116.71 (+2.27)

Monsanto Set to Possibly Rebound After Yesterday's Selloff of 1.15%
Comtex SmarTrend(R) - Wed Oct 29, 3:40PM CDT
Monsanto (NYSE:MON) traded in a range yesterday that spanned from a low of $111.68 to a high of $114.20. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $112.13 on volume of 5.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MON: 116.69 (+2.25)

Monsanto Company Board Sets Record and Meeting Date for Next Shareowners Meeting
Business Wire - Tue Oct 28, 3:30PM CDT
Monsanto Company (NYSE: MON) announced today that its Board of Directors has designated Friday, Jan. 30, 2015 as the date of the next annual meeting of shareowners.
MON: 116.69 (+2.25)

Unlikely Hero: Can Monsanto Rid the World of Pesticides?
Maxx Chatsko, The Motley Fool - Motley Fool - Mon Oct 27, 5:25PM CDT
Source: Stephane Mignon/ Flickr . The United Nations estimates that the global population will increase from 7 billion today to 9 billion people by midcentury. When total population growth is coupled with a swelling global middle class, researchers...
MON: 116.69 (+2.25)

Prospects dim on settlement for all wheat claims
AP - Mon Oct 27, 10:48AM CDT
WICHITA, Kan. (AP) — Prospects are dimming for a settlement on remaining claims in lawsuits over the May 2013 discovery of genetically engineered Monsanto wheat in an Oregon field.
MON: 116.69 (+2.25)

Monsanto (MON) Crosses Pivot Point Support at $112.61
Comtex SmarTrend(R) - Mon Oct 27, 9:02AM CDT
Shares of Monsanto (NYSE:MON) have bearishly opened below the pivot of $113.08 today and have reached the first support level of $112.61. Should the shares continue to fall, the support pivots of $111.94 and $110.80 will be of interest.
MON: 116.69 (+2.25)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Precious Metals and Energy Investors' Strategies

Updated Category News Views 143

Current Trends in Precious Metals The appeal of precious metals like gold and silver continues to gather momentum, particularly in light of recent global events. Many analysts believe that geopolitical tensions have created a catalyst for increased interest in gold as a safe haven. As governments grapple with economic challenges, investors are keenly observing changes in...

Continue Reading
Understanding P/E Ratios in the Context of Casey's General Stores

Updated Category News Views 175

Analyzing P/E Ratios for Investment Decisions In today’s market, understanding the performance metrics of stocks is vital. Currently, Casey's General Stores Inc. (NASDAQ: CASY) is noted at an impressive share price of $536.66. This reflects a modest increase of 0.33%. In examining market trends, the past month saw a slight decline of 4.39% in share value. However,...

Continue Reading
China's New Lending Outlook: Economic Recovery Strategies

Updated Category News Views 135

China's Recent New Lending Trends Recent updates reveal a significant rise in new bank lending in China. However, it didn't quite meet expectations, as analysts had hoped for a stronger performance. After disappointing figures in July, which hit a 15-year low, new data shows that Chinese banks issued around 900 billion yuan (approximately $126.86 billion) in new loans in...

Continue Reading
ParkOhio Shares Important Quarterly Dividend News for Investors

Updated Category News Views 177

ParkOhio Holdings Announces Latest Dividend Declaration Park-Ohio Holdings Corp. (NASDAQ: PKOH) recently declared a significant quarterly cash dividend of $0.125 per share to its common stockholders. This distribution demonstrates the company's ongoing commitment to providing returns to its shareholders. This dividend will be payable soon, marking another positive...

Continue Reading
Investigation Launched for Tourmaline Bio's Shareholders

Updated Category News Views 259

Investigation Overview on Tourmaline Bio, Inc. Recently, Monteverde & Associates PC, a renowned law firm, has initiated an investigation concerning Tourmaline Bio, Inc. (NASDAQ: TRML) and its proposed sale to Novartis AG. This potential acquisition raises several questions about the fairness of the deal, specifically regarding the cash payment offered to shareholders....

Continue Reading